New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:17 EDTRCPTReceptos risk/reward attractive following weakness, says Leerink
Leerink believes Receptos' fundamentals have continued to improve despite the recent share weakness. The firm views the current risk/reward as attractive and reiterates an Overweight rating on the stock with a $75 price target.
News For RCPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 1, 2015
08:10 EDTRCPTReceptos completes enrollment of RADIANCE Phase 3 trial of ozanimod
Subscribe for More Information
March 30, 2015
07:24 EDTRCPTStifel to hold a bus tour
BioTrek: 2015 West Coast Healthcare Therapeutics Bus Tour travels throughout San Francisco on March 30-April 1.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use